miRNA | Ratio of Infected/Non-infected (Normalized) | AIV RNA segments |
---|---|---|
gga-miR-153 | Specifically expressed in infected lung | HA, NA, PA, PB1 and PB2 |
gga-miR-34a | Specifically expressed in infected lung | HA, NA, PA, PB1 and PB2 |
gga-miR-202 | +9.93 | HA, M, NA, NP, NS, PA, PB1 and PB2 |
gga-miR-32 | +7.98 | HA and NS |
gga-miR-211 | +7.45 | HA, M, NA, NP, NS, PA, PB1 and PB2 |
gga-miR-19b | +6.55 | HA, NS, PA and PB1 |
gga-miR-18a | +4.75 | HA, M, NA, PB1 and PB2 |
gga-miR-18b | +3.62 | HA, M, NA, PB1 and PB2 |
gga-miR-155 | +3.55 | HA, NA, NP, NS and PB1 |
gga-miR-15a | +3.48 | HA, M NP, NS and PB2 |
gga-miR-223 | +3.19 | HA, NA, PB1 and PB2 |
gga-miR-30b | +3.06 | M and NA |
gga-miR-142-3p | +2.84 | HA, NA, PA, PB1 and PB2 |
gga-miR-106 | +2.83 | HA, NA, PA, PB1 and PB2 |
gga-miR-20a | +2.78 | HA, NA, NP, PB1 and PB2 |
gga-miR-146a | +2.59 | HA, M, NA, NP, NS, PA, PB1 and PB2 |
gga-miR-20b | +2.41 | HA, M, NA, NP, NS, PB1 and PB2 |
gga-miR-29a | +2.36 | HA, M, NA, NP, PA, PB1 and PB2 |
gga-miR-29c | +2.36 | HA, M, NA, NP, PA and PB1 |
gga-miR-24 | +2.34 | HA, M, NA, NP, NS, PA, PB1 and PB2 |
gga-miR-7b | +2.33 | HA, M, NA, PA, PB1 |
gga-miR-17-5p | +2.32 | HA, M, NA, NP, PA, PB1 and PB2 |
gga-miR-23b | +2.25 | HA, M, PA and PB1 |
gga-miR-17-3p | +2.15 | HA, M, NA, NP, PA and PB2 |
gga-miR-92 | +2.07 | HA, M, NP, NS, PB2 |
gga-miR-206 | −2.86 | HA, NA, NP, PB1 and PB2 |
gga-miR-301 | −3.03 | HA, NA, PB1 and PB2 |
gga-miR-187 | −4.35 | NA, NP, PB1 and PB2 |